When stratified by clinical stage, patients with stage II disease showed a numerical separation of PFS curves between treatment modalities; however, the difference did not reach statistical significance, with the median PFS not reached in the surgery group and 14.0 months in the radiotherapy group (P=0.10; Figure 3A ).
← all excerpts
Surgery versus radiotherapy after neoadjuvant immunochemotherapy in limited-stage small cell lung cancer.
1
0.1000
0.1000